US Patent Issued to DEXCOM on July 8 for "Individualized multiple-day simulation model of type i diabetic patient decision-making for developing, testing and optimizing insulin therapies driven by glucose sensors" (Italian Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,354,751, issued on July 8, was assigned to DEXCOM INC. (San Diego).

"Individualized multiple-day simulation model of type i diabetic patient decision-making for developing, testing and optimizing insulin therapies driven by glucose sensors" was invented by Martina Vettoretti (Valla di Riese, Italy), Andrea Facchinetti (Trissino, Italy), Giovanni Sparacino (Padua, Italy) and Claudio Cobelli (Padua, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "A mathematical model of type 1 diabetes (T1D) patient decision-making can be used to simulate, in silico, realistic glucose/insulin dynamics, for several days, in a variety of subjects who take therapeutic ac...